Adheris Health Ltd (ASX: AHE) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Adheris Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$10.85 million
P/E Ratio
107.69
Dividend Yield
0.00%
Shares Outstanding
637.98 million
Earnings per share
-0.103
Dividend per share
N/A
Year To Date Return
-15.00%
Earnings Yield
0.93%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Adheris Health Ltd (ASX: AHE)
Latest News
Share Fallers
Why Magellan, Medadvisor, Origin Energy, and Pointsbet shares are tumbling today
Healthcare Shares
Up 127% in 2024, why this ASX healthcare stock is surging again this month
Share Gainers
Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising
Share Gainers
Why European Lithium, Evolution, MedAdvisor, and REA shares are charging higher
Earnings Results
3 ASX healthcare shares punished following full-year results
Technology Shares
Why the MedAdvisor (ASX:MDR) share price jumped 12% today
ASX Share Market News
The MedAdvisor (ASX:MDR) share price is lifting today. Here's why
Share Gainers
Why Brickworks, McPherson's, MedAdvisor, & Premier Investments are storming higher
ASX Share Market News
Why the Medadvisor (ASX:MDR) share price is up 11% this week
Share Gainers
Why the MedAdvisor (ASX:MDR) share price is pushing higher today
Speculative
2 ASX small cap healthcare shares growing quickly
Share Fallers
Why Afterpay, Goodman, MedAdvisor, & PointsBet shares are dropping lower
AHE ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Adheris Health Ltd
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. It operates through the following segments: MedAdvisor and Corporate. The MedAdvisor segment includes medication management and adherence platform. The Corporate segment comprises of the company's function associated with being an ASX listed company. MedAdvisor was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.
AHE Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 06 Aug 2026 | $0.02 | $0.00 | 0.00% | 58,827 | $0.02 | $0.02 | $0.01 |
| 05 Aug 2026 | $0.02 | $0.00 | 0.00% | 42,406 | $0.02 | $0.02 | $0.02 |
| 04 Aug 2026 | $0.02 | $0.00 | 0.00% | 8,750 | $0.02 | $0.02 | $0.02 |
| 03 Aug 2026 | $0.02 | $0.00 | 0.00% | 12,080 | $0.02 | $0.02 | $0.02 |
| 30 Jul 2026 | $0.02 | $0.00 | 0.00% | 820,738 | $0.02 | $0.02 | $0.02 |
| 29 Jul 2026 | $0.02 | $0.00 | 0.00% | 886,918 | $0.02 | $0.02 | $0.02 |
| 28 Jul 2026 | $0.02 | $0.00 | 0.00% | 1,101,705 | $0.02 | $0.02 | $0.02 |
| 24 Jul 2026 | $0.02 | $0.00 | 0.00% | 525,000 | $0.02 | $0.02 | $0.02 |
| 23 Jul 2026 | $0.02 | $0.00 | 0.00% | 2,112,687 | $0.02 | $0.02 | $0.02 |
| 22 Jul 2026 | $0.02 | $0.00 | 0.00% | 517,919 | $0.02 | $0.02 | $0.02 |
| 21 Jul 2026 | $0.02 | $0.00 | 0.00% | 474,646 | $0.02 | $0.02 | $0.02 |
| 17 Jul 2026 | $0.02 | $0.00 | 0.00% | 250,000 | $0.02 | $0.02 | $0.02 |
| 14 Jul 2026 | $0.02 | $0.00 | 0.00% | 30,000 | $0.02 | $0.02 | $0.02 |
| 10 Jul 2026 | $0.02 | $0.00 | 0.00% | 649,167 | $0.02 | $0.02 | $0.02 |
| 09 Jul 2026 | $0.02 | $0.00 | 0.00% | 7,095,903 | $0.02 | $0.02 | $0.02 |
| 08 Jul 2026 | $0.02 | $0.00 | 0.00% | 329,420 | $0.01 | $0.02 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 13 May 2026 | John Ciccio | Buy | 639,459 | $13,428 |
On-market trade.
|
| 11 May 2026 | John Ciccio | Buy | 323,541 | $6,734 |
On-market trade.
|
| 10 Apr 2026 | John Ciccio | Issued | 30,000,000 | $540,000 |
Issue of options.
|
| 09 Mar 2026 | Lucas Merrow | Buy | 695,000 | $15,116 |
On-market trade. Average price
|
| 03 Mar 2026 | Lucas Merrow | Buy | 890,000 | $19,580 |
On-market trade. Average price
|
| 02 Mar 2026 | Catherine (Kate) Hill | Buy | 1,500,000 | $30,000 |
On-market trade. Average price
|
| 06 Nov 2025 | Catherine (Kate) Hill | Issued | 500,000 | $50,000 |
Placement.
|
| 06 Nov 2025 | Lucas Merrow | Issued | 500,000 | $50,000 |
Placement.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Catherine (Kate) Jane Hill | Non-Executive DirectorInterim Chairman | May 2023 |
Ms Hill is an experienced auditor and business advisor with over 30 years of experience of working with privately owned companies across a range of business issues. She is an experienced director of small- to mid-cap companies listed on global exchanges, with a record in creating change involving new business models, new markets and new technologies. She is a Member of People Committee and Chair of Risk Committee.
|
| Mr John Murray | Non-Executive Director | Jul 2026 |
Mr Murray is a board director with experience in the international technology sector over the last 35 years, and in a variety of industries including the health sector. John has been non-executive director and Chair of listed and private companies throughout his career, which began in audit and investment banking, involved rising through positions at organisations, and eventually becoming Vice President and Head of Investment Banking at Bank of America Asia in 1989. From there, he joined the Australian Technology Group where he identified and managed investments into early-stage technology companies and went on to co-found the leading venture capital firm, Technology Venture Partners, in 1997. He is a past Chair of the Australian Venture Capital Association. John is currently a Non-Executive Director of UK AIM listed company Seeing Machines Ltd (also Chair of the Risk and Finance Committee) and of ASX listed company PainChek Ltd (where he was also Chair until June 2026).
|
| Mr Lucas Merrow | Non-Executive Director | Aug 2021 |
Mr Merrow co-founded and served as the CEO of Eliza Corporation- health engagement management and patient communications. Eliza Corporation was later acquired. Prior to the founding of Eliza Corporation, Lucas co-founded and served as the COO of Adheris Health, a firm in prescription adherence and patient education programs in the United States. He is a Member of People Committee
|
| Mr John Ciccio | Chief Executive OfficerManaging Director | Nov 2025 |
--
|
| Mr Lee Tamplin | Company Secretary | Apr 2026 |
-
|
| Ancila Desai | Chief Financial Officer |
-
|
|
| Lee Tamplin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 106,641,679 | 17.07% |
| Guild Group Holdings Limited | 94,905,130 | 15.19% |
| J P Morgan Nominees Australia Pty Limited | 59,815,291 | 9.57% |
| Ebos Ph Pty Ltd | 53,986,823 | 8.64% |
| Cotiviti Inc | 43,999,999 | 7.04% |
| Citicorp Nominees Pty Limited | 31,610,031 | 5.06% |
| Bond Street Custodians Limited (Salter D79836 A/C) | 27,550,000 | 4.41% |
| BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient) | 16,278,900 | 2.61% |
| Indcorp Consulting Group Pty Limited (Superannuation Fund A/C) | 7,145,000 | 1.14% |
| Kojent Pty Ltd (Kojent A/C) | 6,846,956 | 1.10% |
| Romida Enterprises Pty Ltd (Romida Family A/C) | 5,642,935 | 0.90% |
| Gread Management Pty Limited (The A G & R R Family A/C) | 5,344,283 | 0.86% |
| Tagdime Pty Ltd (Ian M Davison P/L S/F A/C) | 4,331,854 | 0.69% |
| Dr Christopher Harold Benton | 4,215,000 | 0.67% |
| Provare Pty Ltd (Provare Investment A/C) | 3,743,419 | 0.60% |
| Dmx Capital Partners Limited i | 2,500,000 | 0.40% |
| Dmx Capital Partners Limited | 2,434,351 | 0.39% |
| Celerity Investments Pty Limited | 2,348,978 | 0.38% |
| Hylec Controls Pty Ltd | 2,300,000 | 0.37% |
| Hylec Investments Pty Limited (Hylec Controls P/L S/F A/C) | 2,300,000 | 0.37% |
